$HBIO
HARVARD BIOSCIENCE INC Stock $hbio

$hbio Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-K Financial Statement

#000117184316009551 Filed on April 29, 2016

Income Statement

Concept	2014 Q4	2014 Q3	2014 Q2
Revenue	$30.36M	$25.45M	$26.96M
YoY Change	9.01%	1.24%	3.31%
Cost Of Revenue	$16.50M	$14.01M	$14.68M
YoY Change	4.4%	1.21%	4.82%
Gross Profit	$13.86M	$11.44M	$12.28M
YoY Change	15.06%	1.27%	1.56%
Gross Profit Margin	45.66%	44.96%	45.54%
Selling, General & Admin	$9.570M	$8.243M	$8.554M
YoY Change	27.94%	-6.54%	-2.26%
% of Gross Profit	69.03%	72.04%	69.67%
Research & Development	$1.560M	$1.059M	$1.284M
YoY Change	-191.76%	-45.24%	39.26%
% of Gross Profit	11.25%	9.26%	10.46%
Depreciation & Amortization	$1.090M	$930.0K	$910.0K
YoY Change	13.54%	-3.13%	-9.0%
% of Gross Profit	7.86%	8.13%	7.41%
Operating Expenses	$11.74M	$10.02M	$10.54M
YoY Change	-9.66%	-7.97%	-7.08%
Operating Profit	$2.121M	$1.425M	$1.738M
YoY Change	-323.5%	244.2%	132.98%
Interest Expense	-$210.0K	$239.0K	$248.0K
YoY Change	-41.67%	-13.41%	1.22%
% of Operating Profit	-9.9%	16.77%	14.27%
Other Income/Expense, Net	-$949.0K	-$469.0K	-$468.0K
YoY Change	197.49%	31.01%	41.82%
Pretax Income	$1.172M	$956.0K	$1.270M
YoY Change	-192.43%	1607.14%	205.29%
Income Tax	$1.191M	$323.0K	$248.0K
% Of Pretax Income	101.62%	33.79%	19.53%
Net Earnings	-$19.00K	$633.0K	$1.022M
YoY Change	-97.49%	-164.33%	-649.46%
Net Earnings / Revenue	-0.06%	2.49%	3.79%
Basic Earnings Per Share	$0.00	$0.02	$0.03
Diluted Earnings Per Share	$0.00	$0.02	$0.03
COMMON SHARES
Basic Shares Outstanding	32.42M shares	32.34M shares	32.05M shares
Diluted Shares Outstanding		33.41M shares	32.95M shares

Balance Sheet

Concept	2014 Q4	2014 Q3	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.10M	$26.70M	$26.40M
YoY Change	-45.35%	-27.64%	-22.58%
Cash & Equivalents	$14.13M	$26.73M	$26.43M
Short-Term Investments
Other Short-Term Assets	$4.742M	$4.062M	$1.900M
YoY Change	25.75%	153.88%	26.67%
Inventory	$20.53M	$18.06M	$17.20M
Prepaid Expenses
Receivables	$16.14M	$14.28M	$14.30M
Other Receivables	$4.800M	$4.000M	$4.600M
Total Short-Term Assets	$57.06M	$65.00M	$64.40M
YoY Change	-6.07%	-12.04%	-11.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.190M	$4.109M	$4.100M
YoY Change	18.63%	-10.67%	-6.82%
Goodwill	$39.82M	$35.94M
YoY Change	8.79%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$380.0K	$359.0K	$13.40M
YoY Change	20.25%	-97.2%	8.06%
Total Long-Term Assets	$78.85M	$71.13M	$73.30M
YoY Change	5.55%	-4.4%	0.14%
TOTAL ASSETS
Total Short-Term Assets	$57.06M	$65.00M	$64.40M
Total Long-Term Assets	$78.85M	$71.13M	$73.30M
Total Assets	$135.9M	$136.1M	$137.7M
YoY Change	0.34%	-8.21%	-5.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.294M	$5.100M	$5.100M
YoY Change	34.43%	8.51%	4.08%
Accrued Expenses	$4.452M	$4.132M	$4.600M
YoY Change	-12.33%	-6.09%	21.05%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.000M	$5.000M	$5.000M
YoY Change	0.0%	66.67%	66.67%
Total Short-Term Liabilities	$18.10M	$15.63M	$16.40M
YoY Change	12.52%	15.76%	23.31%
LONG-TERM LIABILITIES
Long-Term Debt	$16.45M	$18.20M	$17.30M
YoY Change	-16.71%	-11.22%	-18.78%
Other Long-Term Liabilities	$4.600M	$5.400M	$5.700M
YoY Change	-8.0%	-12.9%	-1.72%
Total Long-Term Liabilities	$16.45M	$18.20M	$23.00M
YoY Change	-16.71%	-31.84%	-15.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.10M	$15.63M	$16.40M
Total Long-Term Liabilities	$16.45M	$18.20M	$23.00M
Total Liabilities	$40.45M	$39.35M	$39.50M
YoY Change	-1.29%	-2.83%	-2.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$92.68M	-$92.67M
YoY Change	-2.48%
Common Stock	$207.1M	$205.8M
YoY Change	2.08%	53769.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	7.746M shares
Shareholders Equity	$95.47M	$96.78M	$98.20M
YoY Change
Total Liabilities & Shareholders Equity	$135.9M	$136.1M	$137.7M
YoY Change	0.34%	-8.21%	-5.68%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2014 Q2
OPERATING ACTIVITIES
Net Income	-$19.00K	$633.0K	$1.022M
YoY Change	-97.49%	-164.33%	-649.46%
Depreciation, Depletion And Amortization	$1.090M	$930.0K	$910.0K
YoY Change	13.54%	-3.13%	-9.0%
Cash From Operating Activities	$1.260M	$600.0K	$1.420M
YoY Change	0.8%	-58.04%	77.5%
INVESTING ACTIVITIES
Capital Expenditures	-$790.0K	-$480.0K	-$460.0K
YoY Change	49.06%	-5.88%	58.62%
Acquisitions
YoY Change
Other Investing Activities	-$11.59M	$0.00	-$30.00K
YoY Change	-16657.14%	-100.0%
Cash From Investing Activities	-$12.37M	-$480.0K	-$500.0K
YoY Change	2589.13%	-137.8%	72.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.090M	1.360M	-570.0K
YoY Change	-91.27%	-281.33%	-105.88%
NET CHANGE
Cash From Operating Activities	1.260M	600.0K	1.420M
Cash From Investing Activities	-12.37M	-480.0K	-500.0K
Cash From Financing Activities	-1.090M	1.360M	-570.0K
Net Change In Cash	-12.20M	1.480M	350.0K
YoY Change	4.36%	-24.1%	-96.57%
FREE CASH FLOW
Cash From Operating Activities	$1.260M	$600.0K	$1.420M
Capital Expenditures	-$790.0K	-$480.0K	-$460.0K
Free Cash Flow	$2.050M	$1.080M	$1.880M
YoY Change	15.17%	-44.33%	72.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-305000	USD
CY2014Q3	us-gaap	Revenues Revenues	25448000	USD
CY2014Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14006000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	11442000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	10017000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1425000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-469000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	956000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	323000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	633000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33592775	shares
CY2013Q4	hbio	Date Separation Plan Completed DateSeparationPlanCompleted	November 1, 2013
CY2013Q4	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2013-10-21
CY2013Q4	hbio	Spinoff Distribution Ratio SpinoffDistributionRatio	1 for 4
CY2013Q4	hbio	Asset Transfer As Part Of Spinoff AssetTransferAsPartOfSpinoff	900000	USD
CY2013Q1	hbio	Date Private Letter Ruling DatePrivateLetterRuling	22-Mar-13
CY2013Q2	hbio	Date Supplemental Ruling To Private Letter Ruling DateSupplementalRulingToPrivateLetterRuling	28-Jun-13
CY2013Q4	hbio	Taxable Spinoff From Percent Acquired Stock TaxableSpinoffFromPercentAcquiredStock	0.5	pure
CY2013Q4	hbio	Transfer Of Cash And Cash Equivalents To Hart TransferOfCashAndCashEquivalentsToHART	15000000	USD
CY2015	hbio	Service Cost For Defined Benefit Plan ServiceCostForDefinedBenefitPlan	0	USD
CY2014	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Plan Assets DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets	-1029000	USD
CY2015	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Plan Assets DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets	-758000	USD
CY2014	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	1119000	USD
CY2014Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-4446000	USD
CY2014Q4	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	-3557000	USD
CY2014Q4	hbio	Deferred Income Taxes On Pension Liabilities DeferredIncomeTaxesOnPensionLiabilities	889000	USD
CY2014Q4	us-gaap	Defined Benefit Pension Plan Current And Noncurrent Liabilities DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities	4446000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2280000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3557000	USD
CY2015	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0357	pure
CY2014	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0443	pure
CY2013	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0443	pure
CY2013	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0379	pure
CY2014	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0415	pure
CY2015	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0443	pure
CY2015	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0	pure
CY2014	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0	pure
CY2013	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0299	pure
CY2015	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate Support Methodology And Source Data DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportMethodologyAndSourceData	The discount rate assumptions used for pension accounting reflect the prevailing rates available on high-quality, fixed-income debt instruments with terms that match the average expected duration of the Company’s defined benefit pension plan obligations. The Company uses the iBoxx AA 15yr+ index, which matches the average duration of its pension plan liability of approximately 15 years. With the current base of assets in the pension plans, a 0.1% increase/decrease in the discount rate assumption would decrease/increase annual pension expense by approximately $##D<pen-disc-rate-change>.
CY2015Q4	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1	pure
CY2014Q4	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	945000	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.31
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	-413864	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.15
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5022186	shares
CY2015Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	3.85
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.04
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	313559	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	-237188	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.29
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	-10335	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	5.56
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.56
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5718	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0142	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M1D
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	2670000	USD
CY2015Q4	hbio	Percentage Of Outstanding Common Stock PercentageOfOutstandingCommonStock	0.2	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate	0.85	pure
CY2015Q4	hbio	Employee Stock Purchase Plan Shares Authorized EmployeeStockPurchasePlanSharesAuthorized	750000	shares
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	644011	shares
CY2015Q4	hbio	Lender Approval To Fund Acquisition With Cash Promissory Note In Excess Of Threshold LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold	6000000	USD
CY2015Q4	hbio	Lender Approval To Fund Acquisition With Equity In Excess Of Threshold LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold	10000000	USD
CY2009Q3	hbio	Previous Approved Credit Facility PreviousApprovedCreditFacility	20000000	USD
CY2013Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	50000000	USD
CY2013Q1	hbio	Ddtl Threshold For Dollar For Dollar Reduction In Revolving Line DdtlThresholdForDollarForDollarReductionInRevolvingLine	10000000	USD
CY2009Q3	hbio	Interest Rate In Excess Of Libor On Credit Facility InterestRateInExcessOfLiborOnCreditFacility	0.03	pure
CY2015Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	2300000	USD
CY2013Q4	hbio	Transferof Delayed Draw Down Term Loan Capacity To Revolver Capacity TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity	5000000	USD
CY2015	us-gaap	Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred	24000	USD
CY2015	hbio	Derivative Interest Rate Swap Effective Percentage DerivativeInterestRateSwapEffectivePercentage	1	pure
CY2015	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	-4000	USD
CY2014	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	-67000	USD
CY2014	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	56000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	4000	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	310000	USD
CY2014Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	328000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17547000	USD
CY2015Q4	us-gaap	Assets Assets	120217000	USD
CY2015Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1223000	USD
CY2014	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	59319000	USD
CY2014	us-gaap	Gross Profit GrossProfit	49344000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3873000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	22343000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	995000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	1537000	USD
CY2013	us-gaap	Revenues Revenues	105171000	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
CY2013	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	57475000	USD
CY2013	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1020000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2577000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-1713000	USD
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41724772	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33979265	shares
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20872000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	310000	USD
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	7745507	shares
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	42000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	50549000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	319000	USD
CY2015Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	2450000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8782000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	752000	USD
CY2015Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	290000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4021000	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	868000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19409000	USD
CY2015Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	16450000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3775000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2985000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	42619000	USD
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	416000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	211457000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-111723000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11884000	USD
CY2015Q4	us-gaap	Treasury Stock Carrying Basis TreasuryStockCarryingBasis	10668000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	120217000	USD
CY2014	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	2200000	USD
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >(b)</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >Use of Estimates</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' >The preparation of financial</font><font style='font-family:Times New Roman;font-size:10pt;' > statements in conformity with accounting principles generally accepted in the United States requires the use of management estimates. Such estimates include the determination and establishment of certain accruals and provisions, including those for invent</font><font style='font-family:Times New Roman;font-size:10pt;' >ory excess and </font><font style='font-family:Times New Roman;font-size:10pt;' >obsolescence, </font><font style='font-family:Times New Roman;font-size:10pt;' >income tax and reserves for bad debts. In addition, certain estimates are required in order to determine the value of assets and liabilities associated with acquisitions, as well as the Company’s defined benefit pension obligations</font><font style='font-family:Times New Roman;font-size:10pt;' >. Estimates are also required to e</font><font style='font-family:Times New Roman;font-size:10pt;' >valuate the value and recoverability of existing long-lived and intangible assets, including goodwill. On an ongoing basis, the Company reviews its estimates based upon currently available information. Actual results could differ materially from those esti</font><font style='font-family:Times New Roman;font-size:10pt;' >mates.</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ></p></div>
CY2013	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	0	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	46159000	USD
CY2013	us-gaap	Gross Profit GrossProfit	47696000	USD
CY2013	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	17330000	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17887000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4154000	USD
CY2013	us-gaap	Other General Expense OtherGeneralExpense	2048000	USD
CY2013	us-gaap	Restructuring Charges RestructuringCharges	2150000	USD
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-139000	USD
CY2013	us-gaap	Interest Expense InterestExpense	955000	USD
CY2013	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	43000	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-51000	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1102000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	435000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-288000	USD
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	723000	USD
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-2553000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.02
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.08
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2014	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	18225000	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16826000	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4880000	USD
CY2015	us-gaap	Revenues Revenues	108664000	USD
CY2015	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	59941000	USD
CY2015	us-gaap	Gross Profit GrossProfit	48723000	USD
CY2015	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20577000	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19832000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6420000	USD
CY2014	us-gaap	Other General Expense OtherGeneralExpense	0	USD
CY2015	us-gaap	Other General Expense OtherGeneralExpense	0	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	1027000	USD
CY2015	us-gaap	Restructuring Charges RestructuringCharges	788000	USD
CY2014	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	810000	USD
CY2015	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	0	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	42726000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	6618000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	50436000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-150000	USD
CY2014	us-gaap	Interest Expense InterestExpense	990000	USD
CY2014	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	74000	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1135000	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2201000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	210000	USD
CY2015	us-gaap	Interest Expense InterestExpense	854000	USD
CY2015	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	8000	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1259000	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1895000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4417000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2062000	USD
CY2014	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2355000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3608000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15431000	USD
CY2015	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-19039000	USD
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2014	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.07
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-67000	USD
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	172000	USD
CY2015	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2755000	USD
CY2015	us-gaap	Depreciation Depreciation	1745000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.57
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-38000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-11637000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5090000	USD
CY2015	us-gaap	Interest Paid InterestPaid	854000	USD
CY2014	us-gaap	Interest Paid InterestPaid	997000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	963000	USD
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2014	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.07
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2015	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.57
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.02
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.08
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-19039000	USD
CY2013	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2670000	USD
CY2014	us-gaap	Depreciation Depreciation	1253000	USD
CY2013	us-gaap	Depreciation Depreciation	1298000	USD
CY2015	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	0	USD
CY2014	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	0	USD
CY2013	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	440000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-1830000	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-25000	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	810000	USD
CY2013	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2015	hbio	Non Cash Restructuring Charge NonCashRestructuringCharge	-85000	USD
CY2014	hbio	Non Cash Restructuring Charge NonCashRestructuringCharge	-120000	USD
CY2013	hbio	Non Cash Restructuring Charge NonCashRestructuringCharge	-46000	USD
CY2015	hbio	Amortization Of Catalog Costs AmortizationOfCatalogCosts	9000	USD
CY2014	hbio	Amortization Of Catalog Costs AmortizationOfCatalogCosts	47000	USD
CY2013	hbio	Amortization Of Catalog Costs AmortizationOfCatalogCosts	101000	USD
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-7000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2819000	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2578000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2590000	USD
CY2015	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	86000	USD
CY2014	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	61000	USD
CY2013	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	46000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	15116000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1412000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2441000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1340000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	735000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-436000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1223000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3056000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1921000	USD
CY2015	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-755000	USD
CY2014	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	370000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1069000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-41000	USD
CY2015	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-311000	USD
CY2014	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-269000	USD
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	323000	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1511000	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-345000	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	847000	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	120000	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	28000	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	146000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1786000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-836000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-672000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	705000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4351000	USD
CY2015	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	-2960000	USD
CY2014	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	-2005000	USD
CY2013	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	-1622000	USD
CY2015	hbio	Additions To Catalog Costs AdditionsToCatalogCosts	-18000	USD
CY2014	hbio	Additions To Catalog Costs AdditionsToCatalogCosts	0	USD
CY2013	hbio	Additions To Catalog Costs AdditionsToCatalogCosts	-57000	USD
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	6000	USD
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1141000	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	66000	USD
CY2015	hbio	Proceeds From Sale Of Discontinued Operations ProceedsFromSaleOfDiscontinuedOperations	0	USD
CY2014	hbio	Proceeds From Sale Of Discontinued Operations ProceedsFromSaleOfDiscontinuedOperations	0	USD
CY2013	hbio	Proceeds From Sale Of Discontinued Operations ProceedsFromSaleOfDiscontinuedOperations	1784000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4545000	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	12653000	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7517000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13517000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	171000	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	8350000	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5500000	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2750000	USD
CY2015	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	5800000	USD
CY2013	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	14550000	USD
CY2015	hbio	Transfer Of Cash And Cash Equivalents To Hart TransferOfCashAndCashEquivalentsToHART	0	USD
CY2014	hbio	Transfer Of Cash And Cash Equivalents To Hart TransferOfCashAndCashEquivalentsToHART	0	USD
CY2013	hbio	Transfer Of Cash And Cash Equivalents To Hart TransferOfCashAndCashEquivalentsToHART	15041000	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	32000	USD
CY2014	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2013	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	312000	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2042000	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2066000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3621000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-540000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1234000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	68000	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1237000	USD
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	791000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-7390000	USD
CY2013	us-gaap	Interest Paid InterestPaid	892000	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	843000	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	1479000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20681000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25771000	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4051000	USD
CY2013	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	194000	USD
CY2013	hbio	Shares Withheld For Taxes Value SharesWithheldForTaxesValue	1083000	USD
CY2013	us-gaap	Stockholders Equity Note Spinoff Transaction StockholdersEquityNoteSpinoffTransaction	-15949000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	2355000	USD
CY2013	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	282000	shares
CY2013	hbio	Shares Withheld For Taxes SharesWithheldForTaxes	213000	shares
CY2015	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-4936000	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-5941000	USD
CY2013	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1573000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-85000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-99000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-116000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-93000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-130000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-67000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	8000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	31000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-49000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax	-248000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax	-207000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax	-243000	USD
CY2015	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-1029000	USD
CY2014	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-114000	USD
CY2013	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-452000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1277000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-321000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-695000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3651000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5589000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2219000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22690000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3234000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	389000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax	58000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax	52000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax	62000	USD
CY2015	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	241000	USD
CY2014	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	29000	USD
CY2013	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	115000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	40357000	USD
CY2014Q4	us-gaap	Secured Debt SecuredDebt	21450000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2450000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2450000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	14000000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	18900000	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1264000	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1824000	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1055000	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	761000	USD
CY2015Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	132000	USD
CY2014Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	626000	USD
CY2015Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	147000	USD
CY2014Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	240000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1423000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1001000	USD
CY2015Q4	hbio	Total Accrued Expenses TotalAccruedExpenses	4021000	USD
CY2014Q4	hbio	Total Accrued Expenses TotalAccruedExpenses	4452000	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	677000	USD
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	424000	USD
CY2013	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	413000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	673000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	451000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	460000	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-840000	USD
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-182000	USD
CY2013	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-154000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1227000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1503000	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	147000	USD
CY2015	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-12000	USD
CY2014	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-364000	USD
CY2013	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-64000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	82000	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	22000	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	6000	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-161000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	67000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1000	USD
CY2014	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	0	USD
CY2013	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-294000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	-385000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	-615000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1346000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	31000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-34000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	18000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3331000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1846000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2549000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-277000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2571000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2984000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	45000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1416000	USD
CY2014	hbio	Deferred Income Taxes Amount DeferredIncomeTaxesAmount	1611000	USD
CY2014Q4	hbio	Deferred Tax Assets Operating Loss And Credits Carryforwards DeferredTaxAssetsOperatingLossAndCreditsCarryforwards	12803000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	188000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	889000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	2806000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	1832000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19979000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-2423000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	17556000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	27000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	383000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	6431000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	11125000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	45000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1447000	USD
CY2015Q4	hbio	Deferred Tax Assets Operating Loss And Credits Carryforwards DeferredTaxAssetsOperatingLossAndCreditsCarryforwards	14456000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	125000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	535000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	2987000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	2079000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	23402000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-18823000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4579000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	655000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	9563000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-4984000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	191000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	59000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	35000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6744000	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2160000	USD
CY2014	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	233000	shares
CY2014	hbio	Shares Withheld For Taxes SharesWithheldForTaxes	62000	shares
CY2014	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	228000	USD
CY2014	hbio	Shares Withheld For Taxes Value SharesWithheldForTaxesValue	327000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	104213000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	77598000	USD
CY2012Q4	us-gaap	Shares Issued SharesIssued	37124000	shares
CY2015	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	0	USD
CY2014	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	0	USD
CY2013	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	288000	USD
CY2014	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	893000	USD
CY2013	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	797000	USD
CY2015	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	668000	USD
CY2014	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	649000	USD
CY2013	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	524000	USD
CY2015	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-306000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	719000	USD
CY2014Q2	us-gaap	Revenues Revenues	26958000	USD
CY2013Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	15540000	USD
CY2014Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	16724000	USD
CY2014	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-259000	USD
CY2013Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	20403000	USD
CY2015	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	752000	USD
CY2015	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments	0	USD
CY2014	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments	0	USD
CY2013	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments	197000	USD
CY2015	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	349000	USD
CY2014	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	503000	USD
CY2013	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	669000	USD
CY2014	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	1628000	USD
CY2014	hbio	Service Cost For Defined Benefit Plan ServiceCostForDefinedBenefitPlan	0	USD
CY2014	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	-1302000	USD
CY2014	us-gaap	Defined Benefit Plan Benefits Paid DefinedBenefitPlanBenefitsPaid	-457000	USD
CY2014	us-gaap	Defined Benefit Plan Contributions By Plan Participants DefinedBenefitPlanContributionsByPlanParticipants	5000	USD
CY2014	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1546000	USD
CY2015	us-gaap	Defined Benefit Plan Benefits Paid DefinedBenefitPlanBenefitsPaid	-1021000	USD
CY2015	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	711000	USD
CY2015	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-1360000	USD
CY2015	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	70000	USD
CY2015Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	18582000	USD
CY2014Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	21170000	USD
CY2015Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-2815000	USD
CY2015Q4	hbio	Deferred Income Taxes On Pension Liabilities DeferredIncomeTaxesOnPensionLiabilities	535000	USD
CY2015Q4	us-gaap	Defined Benefit Pension Plan Current And Noncurrent Liabilities DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities	2815000	USD
CY2015Q4	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	-2280000	USD
CY2013	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-310000	USD
CY2015Q4	us-gaap	Noncurrent Assets NoncurrentAssets	26774000	USD
CY2014Q4	us-gaap	Noncurrent Assets NoncurrentAssets	26343000	USD
CY2015Q4	hbio	Segment Reporting Information Net Assets1 SegmentReportingInformationNetAssets1	77598000	USD
CY2014Q4	hbio	Segment Reporting Information Net Assets1 SegmentReportingInformationNetAssets1	95468000	USD
CY2013	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-8000	USD
CY2013	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	172000	USD
CY2013	hbio	Valuation Allowances And Reserves Currency Translation ValuationAllowancesAndReservesCurrencyTranslation	0	USD
CY2014	hbio	Valuation Allowances And Reserves Currency Translation ValuationAllowancesAndReservesCurrencyTranslation	-19000	USD
CY2015	hbio	Valuation Allowances And Reserves Currency Translation ValuationAllowancesAndReservesCurrencyTranslation	-18000	USD
CY2012Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	194000	USD
CY2013Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	358000	USD
CY2015Q3	us-gaap	Revenues Revenues	25731000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	2246000	USD
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	2121000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-321000	USD
CY2014Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-949000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1096000	USD
CY2014Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1172000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-249000	USD
CY2014Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1191000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-847000	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-19000	USD
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2014Q4	us-gaap	Revenues Revenues	30364000	USD
CY2015Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14005000	USD
CY2014Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16501000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	11726000	USD
CY2014Q4	us-gaap	Gross Profit GrossProfit	13863000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	12501000	USD
CY2014Q4	us-gaap	Operating Expenses OperatingExpenses	11742000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-775000	USD
CY2015	hbio	Minimun Percentage Of Term Loan And Delayed Draw Term Loan On Which Interest Rate Required To Be Fixed MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed	0.5	pure
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30384010	shares
CY2013	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1529789	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31913799	shares
CY2015	dei	Trading Symbol TradingSymbol	HBIO
CY2015	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	-918000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5902000	USD
CY2016Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34041949	shares
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015	dei	Entity Registrant Name EntityRegistrantName	HARVARD BIOSCIENCE INC
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	10957000	USD
CY2015Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	888000	USD
CY2015Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	10498000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21920000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16018000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1843000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1749000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1727000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1526000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1527000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	4193000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	12565000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2800000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2700000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2500000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2300000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2200000	USD
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q4	hbio	Total Indefinite Lived Intangible Assets Including Goodwill TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill	41580000	USD
CY2015Q4	hbio	Total Intangible Assets TotalIntangibleAssets	89159000	USD
CY2015	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1618000	USD
CY2014	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	-102000	USD
CY2014	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	49000	USD
CY2015Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	147000	USD
CY2014Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	252000	USD
CY2015	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	-81000	USD
CY2015	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	-24000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14134000	USD
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0001123494
CY2015	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-3992000	USD
CY2015	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-341000	USD
CY2015Q4	us-gaap	Secured Debt SecuredDebt	18900000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20200000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15010000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	10138000	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	946000	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	9447000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	47579000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-26707000	USD
CY2014Q4	hbio	Total Indefinite Lived Intangible Assets Including Goodwill TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill	41074000	USD
CY2014Q4	hbio	Total Intangible Assets TotalIntangibleAssets	86712000	USD
CY2013Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	305000	USD
CY2014	hbio	Fair Value Impairment Of Pension Assets FairValueImpairmentOfPensionAssets	0	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	254685	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.4097	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5578	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0172	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.018	pure
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M0D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M3D
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	2755000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	2156000	USD
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33592775	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32170683	shares
CY2015	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2014	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1065886	shares
CY2014Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	3.42
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33236569	shares
CY2015	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	58823	shares
CY2015Q2	hbio	Increase In Number Of Shares Authorized For Issuance Under Stock Option And Incentive Plan IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan	2500000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	17508929	shares
CY2015Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	80000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	100000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	94485000	USD
CY2014Q1	us-gaap	Revenues Revenues	25893000	USD
CY2014Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14132000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	11761000	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	10427000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1334000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-315000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1019000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	USD
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2014Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14680000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	12278000	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	10540000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1738000	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-468000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1270000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	248000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	1022000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2644000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-5926000	USD
CY2014	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-337000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	45638000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-24485000	USD
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1700000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	36605000	USD
CY2014	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4691000	USD
CY2014	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-1474000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2100000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1300000	USD
CY2015Q2	dei	Entity Public Float EntityPublicFloat	183544144	USD
CY2015Q2	hbio	Non Affiliate Share Holding NonAffiliateShareHolding	32200727	shares
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16141000	USD
CY2014Q4	us-gaap	Assets Assets	135916000	USD
CY2014Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1252000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4742000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	20531000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	11056000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21153000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	328000	USD
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40308763	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32563256	shares
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	7745507	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	1515000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	57063000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	380000	USD
CY2014Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	5000000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6294000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	655000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	554000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4452000	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1023000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18099000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	16450000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1325000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	4574000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	40448000	USD
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	397000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	206656000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-92684000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8233000	USD
CY2014Q4	us-gaap	Treasury Stock Carrying Basis TreasuryStockCarryingBasis	10668000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	135916000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	39822000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	121000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5190000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	95468000	USD
CY2014	us-gaap	Revenues Revenues	108663000	USD
CY2015Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	15767000	USD
CY2015	us-gaap	Defined Benefit Plan Contributions By Plan Participants DefinedBenefitPlanContributionsByPlanParticipants	0	USD
CY2015Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	600000	USD
CY2015Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	600000	USD
CY2015Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	500000	USD
CY2015Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	700000	USD
CY2015Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	600000	USD
CY2015Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	4000000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	500000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	285000	USD
CY2013	hbio	Deferred Income Taxes Amount DeferredIncomeTaxesAmount	-748000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	250000	USD
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	500000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	600000	USD
CY2015	us-gaap	Defined Benefit Plans Estimated Future Employer Contributions In Next Fiscal Year DefinedBenefitPlansEstimatedFutureEmployerContributionsInNextFiscalYear	800000	USD
CY2015	hbio	Current Federal And State Income Tax Expense Benefit Continuing Operations CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations	-4000	USD
CY2014	hbio	Current Federal And State Income Tax Expense Benefit Continuing Operations CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations	27000	USD
CY2013	hbio	Current Federal And State Income Tax Expense Benefit Continuing Operations CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations	47000	USD
CY2015	hbio	Business Acquisition Direct Acquisition Costs In Income Statement BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement	1200000	USD
CY2014	hbio	Business Acquisition Direct Acquisition Costs In Income Statement BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement	1100000	USD
CY2015	hbio	Deferred Federal And State Income Tax Expense Benefit Continuing Operations DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations	15598000	USD
CY2014	hbio	Deferred Federal And State Income Tax Expense Benefit Continuing Operations DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations	1793000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.62
CY2013	hbio	Business Acquisition Direct Acquisition Costs In Income Statement BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement	0	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6263112	shares
CY2013	hbio	Deferred Federal And State Income Tax Expense Benefit Continuing Operations DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations	-594000	USD
CY2015	hbio	Deferred Income Taxes Amount DeferredIncomeTaxesAmount	14758000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.07
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	306397	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.3
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6690845	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	463973	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8078509	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	677193	shares
CY2013Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	3.42
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.32
CY2012Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	4.25
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.97
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	116400	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	-233098	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	-40878	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	259931	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	-281650	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	-191501	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.12
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.36
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.18
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.67
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.08
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.44
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	5.26
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.2
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1115300	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	-847860	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3349052	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	-1326233	shares
CY2014	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	57848	shares
CY2013	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	56938	shares
CY2015Q4	hbio	Incentive Stock Options Granted To Date IncentiveStockOptionsGrantedToDate	10218057	shares
CY2014Q4	hbio	Incentive Stock Options Granted To Date IncentiveStockOptionsGrantedToDate	10218057	shares
CY2013Q4	hbio	Incentive Stock Options Granted To Date IncentiveStockOptionsGrantedToDate	10218057	shares
CY2015Q4	hbio	Non Qualified Stock Options Granted To Date NonQualifiedStockOptionsGrantedToDate	13088374	shares
CY2014Q4	hbio	Non Qualified Stock Options Granted To Date NonQualifiedStockOptionsGrantedToDate	12143374	shares
CY2013Q4	hbio	Non Qualified Stock Options Granted To Date NonQualifiedStockOptionsGrantedToDate	11028074	shares
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5521283	shares
CY2015Q1	us-gaap	Gross Profit GrossProfit	11478000	USD
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2526441	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2547580	shares
CY2013Q4	hbio	Incremental Options Granted Due To Hart Spinoff IncrementalOptionsGrantedDueToHartSpinoff	1715164	shares
CY2013Q4	hbio	Incremental Units Granted Due To Hart Spinoff IncrementalUnitsGrantedDueToHartSpinoff	135650	shares
CY2015Q4	hbio	In The Money Stock Options Exercisable At The Reporting Date InTheMoneyStockOptionsExercisableAtTheReportingDate	1196226	shares
CY2015Q4	hbio	Common Stock Market Value Per Share On Reporting Date CommonStockMarketValuePerShareOnReportingDate	3.47
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	800000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1800000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5100000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M4D
CY2015Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4200000	USD
CY2015	hbio	Annualized Estimated Forfeiture Rate AnnualizedEstimatedForfeitureRate	0.0806	pure
CY2014	hbio	Annualized Estimated Forfeiture Rate AnnualizedEstimatedForfeitureRate	0.0705	pure
CY2013	hbio	Annualized Estimated Forfeiture Rate AnnualizedEstimatedForfeitureRate	0.0654	pure
CY2015	hbio	Weighted Average Estimated Black Scholes Value Of Option Grants WeightedAverageEstimatedBlackScholesValueOfOptionGrants	2.12
CY2014	hbio	Weighted Average Estimated Black Scholes Value Of Option Grants WeightedAverageEstimatedBlackScholesValueOfOptionGrants	2.18
CY2013	hbio	Weighted Average Estimated Black Scholes Value Of Option Grants WeightedAverageEstimatedBlackScholesValueOfOptionGrants	2.41
CY2013	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	-179000	USD
CY2013	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	262000	USD
CY2012Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	222000	USD
CY2015Q1	us-gaap	Revenues Revenues	25763000	USD
CY2015Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14285000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	12628000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1150000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-614000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1764000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-363000	USD
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2015Q4	us-gaap	Revenues Revenues	28370000	USD
CY2015Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15446000	USD
CY2015Q4	us-gaap	Gross Profit GrossProfit	12924000	USD
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	12811000	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	113000	USD
CY2015Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-434000	USD
CY2015Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-321000	USD
CY2015Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16819000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-17140000	USD
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2015Q2	us-gaap	Revenues Revenues	28800000	USD
CY2015Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16205000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	12595000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	12496000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	99000	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-526000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-427000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-776000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	349000	USD
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2015	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >(s)</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >Recently Issued Accounting Pronouncements</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >“Revenue from Contracts with Customers,”</font><font style='font-family:Times New Roman;font-size:10pt;' > a new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance within generally accepted accounting principles in th</font><font style='font-family:Times New Roman;font-size:10pt;' >e United States. Under this standard, revenue will be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or servi</font><font style='font-family:Times New Roman;font-size:10pt;' >ces. At its July 2015 meeting, the FASB agreed to defer the mandatory effective date of ASU 2014-09 one year. Under the one year deferral, the standard will take effect in 2018 for calendar year-end public entities. The Company is assessing the new standar</font><font style='font-family:Times New Roman;font-size:10pt;' >d and has not yet determined the impact to the consolidated financial statements.</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' > </font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In April 2015, the FASB issued ASU 2015-03, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs</font><font style='font-family:Times New Roman;font-size:10pt;' >. The update requires de</font><font style='font-family:Times New Roman;font-size:10pt;' >bt issuance costs related to a recognized debt liability to be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability, instead of being presented as an asset. Debt disclosures will include the face amoun</font><font style='font-family:Times New Roman;font-size:10pt;' >t of the debt liability and the effective interest rate. The update requires retrospective application and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2015.  Early adoption is permitted</font><font style='font-family:Times New Roman;font-size:10pt;' > for financial statements that have not been previously issued. The Company believes the adoption of this new guidance will not have a material impact on its consolidated financial position or results of operations.</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' > </font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In July 2015, the FASB </font><font style='font-family:Times New Roman;font-size:10pt;' >issued ASU 2015-11, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Simplifying Measurement of Inventory</font><font style='font-family:Times New Roman;font-size:10pt;' >. The update requires measurement of most inventory “at the lower of cost and net realizable value”, and applies to all entities that recognize inventory within the scope of ASC 330, except for invent</font><font style='font-family:Times New Roman;font-size:10pt;' >ory measured under the last-in, first-out (LIFO) method or the retail inventory method (RIM). ASU 2015-11 requires prospective application and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15</font><font style='font-family:Times New Roman;font-size:10pt;' >, 2016.  Early adoption is permitted for financial statements that have not been previously issued. The Company is evaluating the impact of ASU 2015-11 on its consolidated financial statements and the possibility of early adoption by the Company.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In Septe</font><font style='font-family:Times New Roman;font-size:10pt;' >mber 2015, the FASB issued ASU 2015-16, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Simplifying the Accounting for Measurement-Period Adjustments</font><font style='font-family:Times New Roman;font-size:10pt;' >. The update eliminates the requirement to retrospectively adjust financial statements for measurement-period adjustments that occur in periods after a bus</font><font style='font-family:Times New Roman;font-size:10pt;' >iness combination. Under the update, measurement-period adjustments are to be calculated as if they were known at the acquisition date, but are recognized in the reporting period in which they are determined. Additional disclosures are required about the i</font><font style='font-family:Times New Roman;font-size:10pt;' >mpact on current-period earnings. ASU 2015-16 requires prospective application to adjustments of provisional amounts that occur after the effective date. The update is effective for fiscal years beginning after December 15, 2016.  Early adoption is permitt</font><font style='font-family:Times New Roman;font-size:10pt;' >ed for financial statements that have not been previously issued. The Company is evaluating the impact of ASU 2015-16 on its consolidated financial statements and the possibility of early adoption by the Company.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:inherit;font-size:10pt;margin-left:24.5pt;color:#000000;' >In November 2015, the FASB issued </font><font style='font-family:Times New Roman;font-size:10pt;' >ASU 2015</font><font style='font-family:Times New Roman;font-size:10pt;' >-17, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Balance Sheet Classification of Deferred Taxes</font><font style='font-family:Times New Roman;font-size:10pt;' >. </font><font style='font-family:inherit;font-size:10pt;color:#000000;' >The update requires all deferred income taxes to be presented on the balance sheet as noncurrent. The new guidance is intended to simplify financial reporting by eliminating the requirement to classify d</font><font style='font-family:inherit;font-size:10pt;color:#000000;' >eferred taxes between current and noncurrent. </font><font style='font-family:Times New Roman;font-size:10pt;' >The update is effective for fiscal years beginning after December 15, 2016.  Early adoption is permitted at the beginning of an interim or annual period. The Company is evaluating the impact of ASU 2015-17 on i</font><font style='font-family:Times New Roman;font-size:10pt;' >ts consolidated financial statements and the possibility of early adoption by the Company.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In February 2016, the FASB issued ASU 2016-02, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Leases</font><font style='font-family:Times New Roman;font-size:10pt;' >, </font><font style='font-family:Times;font-size:10pt;color:#000000;' >which</font><font style='font-family:Times;font-size:10pt;color:#000000;' > is intended to improve financial reporting about leasing transactions. The update requires a lessee to </font><font style='font-family:Times;font-size:10pt;color:#000000;' >record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12 months. The update is effective for fiscal years beginning after December 15, 2018. The Company is evaluating the impact of ASU 201</font><font style='font-family:Times;font-size:10pt;color:#000000;' >6-02 on its consolidated financial statements.</font></p></div>
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2015Q4	hbio	Net Operating Loss Carryforward Federal And State NetOperatingLossCarryforwardFederalAndState	29600000	USD
CY2015Q4	hbio	Net Operating Loss Carryforward Foreign NetOperatingLossCarryforwardForeign	7200000	USD
CY2015Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	4600000	USD
CY2015Q4	hbio	Cash In Foreign Subsidiaries CashInForeignSubsidiaries	5700000	USD
CY2015Q4	hbio	Undistributed Foreign Earnings UndistributedForeignEarnings	48700000	USD
CY2013Q4	hbio	Undistributed Foreign Earnings UndistributedForeignEarnings	49200000	USD
CY2014Q4	hbio	Undistributed Foreign Earnings UndistributedForeignEarnings	51900000	USD
CY2014Q4	hbio	Cash In Foreign Subsidiaries CashInForeignSubsidiaries	12700000	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	16700000	USD
CY2015Q4	hbio	Net Operating Loss Carryforwards Subject To Annual Limitation NetOperatingLossCarryforwardsSubjectToAnnualLimitation	5400000	USD
CY2015Q4	hbio	Net Operating Loss Carryforwards Annual Limitation NetOperatingLossCarryforwardsAnnualLimitation	700000	USD
CY2015Q4	hbio	Cash Held In Foreign Subsidiaries Used For Foreign Capital Improvements CashHeldInForeignSubsidiariesUsedForForeignCapitalImprovements	300000	USD
CY2015Q4	hbio	Tax Liability On Foreign Earnings Repatriated TaxLiabilityOnForeignEarningsRepatriated	1700000	USD
CY2015	us-gaap	Foreign Earnings Repatriated ForeignEarningsRepatriated	3200000	USD
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2015	hbio	Shares Withheld For Taxes Value SharesWithheldForTaxesValue	773000	USD
CY2015	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	208000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2630000	USD
CY2015	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	237000	shares
CY2015	hbio	Shares Withheld For Taxes SharesWithheldForTaxes	652000	shares
CY2013Q4	us-gaap	Shares Issued SharesIssued	39385000	shares
CY2014Q4	us-gaap	Shares Issued SharesIssued	40309000	shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2135000	shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	695000	shares
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1772000	shares
CY2014	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2156000	USD
CY2015	us-gaap	Goodwill Other Changes GoodwillOtherChanges	372000	USD
CY2015	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-1455000	USD
CY2015	hbio	Net Change In Income Tax Expense Benefit Resulting From Permanent Differences NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences	32000	USD
CY2014	hbio	Net Change In Income Tax Expense Benefit Resulting From Permanent Differences NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences	-93000	USD
CY2013	hbio	Net Change In Income Tax Expense Benefit Resulting From Permanent Differences NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences	482000	USD
CY2015	hbio	Net Impact Of Foreign Rate Changes NetImpactOfForeignRateChanges	89000	USD
CY2014	hbio	Net Impact Of Foreign Rate Changes NetImpactOfForeignRateChanges	0	USD
CY2013	hbio	Net Impact Of Foreign Rate Changes NetImpactOfForeignRateChanges	0	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	-169000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	35000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-9000	USD
CY2015Q4	hbio	Deferred Tax Assets Tax Credits On Repatriation DeferredTaxAssetsTaxCreditsOnRepatriation	1728000	USD
CY2014Q4	hbio	Deferred Tax Assets Tax Credits On Repatriation DeferredTaxAssetsTaxCreditsOnRepatriation	0	USD
CY2015Q4	hbio	Deferred Tax Liabilities Indefinite Lived Intangible Assets DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets	4593000	USD
CY2014Q4	hbio	Deferred Tax Liabilities Indefinite Lived Intangible Assets DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets	4291000	USD
CY2015Q4	hbio	Deferred Tax Liabilities Definite Lived Intangible Assets DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets	2587000	USD
CY2014Q4	hbio	Deferred Tax Liabilities Definite Lived Intangible Assets DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets	1730000	USD
CY2015Q4	hbio	Deferred Tax Liabilities On Repatriation DeferredTaxLiabilitiesOnRepatriation	1728000	USD
CY2014Q4	hbio	Deferred Tax Liabilities On Repatriation DeferredTaxLiabilitiesOnRepatriation	0	USD
CY2015	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	370000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	16401000	USD
CY2015Q4	hbio	Additional Paid In Capital Net Operating Loss Impact On Deferred Tax Assets AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets	900000	USD
CY2014Q4	hbio	Additional Paid In Capital Net Operating Loss Impact On Deferred Tax Assets AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets	200000	USD
CY2015	hbio	Defined Benefit Plan Increase Decrease In Discount Rate Percentage DefinedBenefitPlanIncreaseDecreaseInDiscountRatePercentage	0.001	pure
CY2015	hbio	Defined Benefit Plan Increase Decrease In Asset Return Percentage DefinedBenefitPlanIncreaseDecreaseInAssetReturnPercentage	0.001	pure
CY2015	hbio	Defined Benefit Plan Increase Decrease In Discount Rate Value DefinedBenefitPlanIncreaseDecreaseInDiscountRateValue	56000	USD
CY2015	hbio	Defined Benefit Plan Increase Decrease In Asset Return Value DefinedBenefitPlanIncreaseDecreaseInAssetReturnValue	16000	USD
CY2015	hbio	Defined Benefit Plan Average Pension Plan Liability DefinedBenefitPlanAveragePensionPlanLiability	P15Y
CY2015	hbio	Defined Benefit Plan Average Remaining Work Lifetime DefinedBenefitPlanAverageRemainingWorkLifetime	P15Y
CY2015Q4	us-gaap	Shares Issued SharesIssued	41725000	shares

Files In Submission

Name	View Source	Status
0001171843-16-009551-index-headers.html	Edgar Link	pending
0001171843-16-009551-index.html	Edgar Link	pending
0001171843-16-009551.txt	Edgar Link	pending
0001171843-16-009551-xbrl.zip	Edgar Link	pending
exh_1020.htm	Edgar Link	pending
exh_1044.htm	Edgar Link	pending
exh_211.htm	Edgar Link	pending
exh_231.htm	Edgar Link	pending
exh_311.htm	Edgar Link	pending
exh_312.htm	Edgar Link	pending
exh_321.htm	Edgar Link	pending
exh_322.htm	Edgar Link	pending
f10k_042916.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
graph.jpg	Edgar Link	pending
hbio-20151231.xml	Edgar Link	completed
hbio-20151231.xsd	Edgar Link	pending
hbio-20151231_cal.xml	Edgar Link	unprocessable
hbio-20151231_def.xml	Edgar Link	unprocessable
hbio-20151231_lab.xml	Edgar Link	unprocessable
hbio-20151231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HBIO
HARVARD BIOSCIENCE INC Stock $hbio

2014 Q4 Form 10-K Financial Statement

#000117184316009551 Filed on April 29, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HBIO HARVARD BIOSCIENCE INC Stock $hbio

2014 Q4 Form 10-K Financial Statement

#000117184316009551 Filed on April 29, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HBIO
HARVARD BIOSCIENCE INC Stock $hbio